Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Stoke Therapeutics is a U.S. biotechnology company specializing in the development of novel RNA-based medicines. Through its proprietary TANGO platform, the company addresses the underlying genetic causes of severe diseases to precisely regulate protein production and restore therapeutic balance.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Stoke Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Stoke Therapeutics last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.93 USD.
Stoke Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.